Clinical Digital Assistant from US health tech company Oracle to harness generative AI

US health tech company Oracle has announced that it will be harnessing generative AI technology to help clinicians reduce administrative pressures.

Integrated with Oracle’s EHR solutions, the Oracle Clinical Digital Assistant is said to be designed to make it easier for patients to schedule appointments and check clinical information using simple voice commands. The AI can also help patients with questions such as “what happens during a colonoscopy?”, as well as providing reminders for required paperwork prior to their next appointment.

From a clinician’s perspective, the solution automates note taking during the appointment, and proposes “context-aware next actions” including ordering medications and scheduling labs or follow-up appointments.

Providers are also able to use voice commands to interact with the AI, asking things like, “show me the patient’s latest MRI results”, or looking up details from the EHR record during an appointment. Results are shown in relevant order, which “helps the physician gain insight into the appropriate treatment path without requiring a multi-menu, multi-step interaction with the EHR”.

The Oracle Clinical Digital Assistant will be available by September 2024.

Suhas Uliyar, senior vice president of product management at Oracle Health, said: “The EHR should be a provider’s best ally in delivering engaging, personalized care to the patients they serve. By bringing comprehensive generative AI and voice-first capabilities to our EHR platforms, we are not only helping providers reduce mundane work that leads to burnout, but we are also empowering them to create better interactions with patients that establish trust, build loyalty, and deliver better outcomes.”

Also in AI, the World Health Organization (WHO), with support from the Qatar Ministry of Health, has launched an artificial intelligence digital health worker, Florence, which is capable of sharing advice and information on a range of health topics, in seven different languages.

In the US, the FDA has granted clearance for UltraSight’s AI-powered ultrasound guidance technology, which is designed to “assist medical professionals without sonography experience in acquiring cardiac ultrasound images at the point of care in multiple settings”, with the aim of supporting detection of heart disease and providing patients with easier access to cardiac monitoring.